Swedencare Q1 sales growth weighed by strong krona; sees dermatology segment growth later in FY

Swedencare AB (publ)

23/04/2026 06:45

Overview

Sweden pet healthcare products maker's Q1 revenue rose 1% yr/yr, organic growth 11%

Adjusted EBITDA for Q1 increased 3% with margin up to 19.6%

EPS fell to SEK 0.11 from SEK 0.15 a year earlier

Outlook

Company expects dermatology segment to return to growth later in the year

Swedencare aims to normalize NaturVet Amazon cost levels by second half of year

Company sees positive outlook for Pharma and EU-based production in coming quarters

Result Drivers

CURRENCY IMPACT - Revenue growth was limited by a stronger Swedish krona, which offset higher organic growth, per CEO

SEGMENT PERFORMANCE - Organic growth exceeded 20% in Europe and production, while North America saw 5% growth, with lower private label volumes offset by proprietary brands

NATURVET AMAZON TRANSITION - Transition of NaturVet’s Amazon sales continued to affect margins, but company said cost levels were gradually improving

Company press release: ID:nMFNbjY0Xq

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
SEK 650.30 mln
Q1 EPS
SEK 0.11
Q1 Net Income
SEK 17.70 mln
Q1 Adjusted EBITDA
SEK 127.70 mln
Q1 Adjusted EBIT
SEK 102.60 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the pharmaceuticals peer group is "buy"

Wall Street's median 12-month price target for Swedencare AB (publ) is SEK49.00, about 77.9% above its April 22 closing price of SEK27.55

The stock recently traded at 21 times the next 12-month earnings vs. a P/E of 24 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)